RIT and UR professors awarded patent for use of carbon nanotubes for improving delivery of bio-therapies to targeted cells
Technology collaboration could provide safer and less damaging effects of administering agents to cells
Professors from Rochester Institute of Technology and the University of Rochester Medical Center have received a patent to deliver biomolecules into cells through carbon nanotube arrays.
Ian Dickerson, associate professor in the Del Monte Institute for Neuroscience at the University of Rochester, and Michael Schrlau, associate professor of mechanical engineering in RIT’s Kate Gleason College of Engineering, developed the technology that will support inter-cell transfer of bio-therapies to targeted cells.